T 0177/13 (ENTERIC SOLID ORAL DOSAGE FORM OF A BISPHOSPHONATE CONTAINING A CHELATING AGENT/Warner Chilcott Company, LLC) of 11.06.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T017713.20150611
- Date of decision
- 11 June 2015
- Case number
- T 0177/13
- Petition for review of
- -
- Application number
- 05735411.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- ENTERIC SOLID ORAL DOSAGE FORM OF A BISPHOSPHONATE CONTAINING A CHELATING AGENT
- Applicant name
- Warner Chilcott Company, LLC
- Opponent name
- APOTEX INC.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention R 80Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Late filed requests not admitted into the proceedings - Main request, auxiliary request 3
Late filed requests admitted into the proceedings - Auxiliary requests 1, 1A
Inventive step - Auxiliary requests 1, 1A, 2 (no)
Inventive step - technical prejudice in the art (no)
Inventive step - Obvious multiple selections - Catchword
- -
- Cited cases
- G 0002/08
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.